| Q42121483 | Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone |
| Q37703462 | Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis |
| Q35954667 | Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis pat |
| Q33793523 | Further optimization of the reliability of the 28-joint disease activity score in patients with early rheumatoid arthritis |
| Q35557868 | Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study |
| Q79819723 | Patients with active rheumatoid arthritis but only few tender and swollen joints: a subgroup with impaired short term outcome |
| Q47153964 | Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis |
| Q42962044 | Response to the commentary 'Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind'. |
| Q83139262 | Retrospective clinical study of the efficacy of lower-dose methotrexate and infliximab therapy in patients with rheumatoid arthritis |
| Q83774566 | Serum adenosine deaminase may predict disease activity in rheumatoid arthritis |
| Q36194217 | Severity and Diurnal Improvement of Morning Stiffness Independently Associate with Tenosynovitis in Patients with Rheumatoid Arthritis. |
| Q30631701 | Stiffness is more than just duration and severity: a qualitative exploration in people with rheumatoid arthritis |
| Q33382532 | The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study |
| Q40586509 | The contribution of four immunogenetic markers for predicting persistent activity in patients with recent-onset rheumatoid arthritis or undifferentiated arthritis |
| Q36790324 | The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? |